450 results on '"Molina, Julian"'
Search Results
2. Neoadjuvant pembrolizumab plus chemotherapy followed by adjuvant pembrolizumab compared with neoadjuvant chemotherapy alone in patients with early-stage non-small-cell lung cancer (KEYNOTE-671): a randomised, double-blind, placebo-controlled, phase 3 trial
3. Real-World Outcomes With Lurbinectedin in Second-Line Setting and Beyond for Extensive Stage Small Cell Lung Cancer
4. Correction to: PFKFB3 regulates cancer stemness through the hippo pathway in small cell lung carcinoma
5. PFKFB3 works on the FAK-STAT3-SOX2 axis to regulate the stemness in MPM
6. Time from immune checkpoint inhibitor to sotorasib use correlates with risk of hepatotoxicity in non-small cell lung cancer: A brief report
7. PFKFB3 regulates cancer stemness through the hippo pathway in small cell lung carcinoma
8. Vulnerability and COVID-19 infection rates: A changing relationship during the first year of the pandemic
9. A Randomized, Open-Label Phase II Study Evaluating Emibetuzumab Plus Erlotinib and Emibetuzumab Monotherapy in MET Immunohistochemistry Positive NSCLC Patients with Acquired Resistance to Erlotinib
10. Advancing head and neck cancer management: Unveiling the diagnostic and therapeutic potentials of molecular profiling.
11. Intervention work : an ethnography of 'NEET to EET' transitions
12. Salicylates enhance CRM1 inhibitor antitumor activity by induction of S-phase arrest and impairment of DNA-damage repair
13. Scrutinising Statistics, Questioning BME Unemployment: The Uses of Labour Market Statistics in Parliamentary Select Committee Evidence Sessions
14. Detecting HLA loss of heterozygosity within a standard diagnostic sequencing workflow for prognostic and therapeutic opportunities.
15. The Home Office's Racism Studies Before the Macpherson Inquiry: Revisiting Administrative Criminology's Corpus.
16. Cardiovascular Health and Outcomes in Cancer Patients Receiving Immune Checkpoint Inhibitors
17. Distribution of Mediastinal Lesions Across Multi-Institutional, International, Radiology Databases
18. A Randomized Double-Blind Phase II Study of the Seneca Valley Virus (NTX-010) versus Placebo for Patients with Extensive-Stage SCLC (ES SCLC) Who Were Stable or Responding after at Least Four Cycles of Platinum-Based Chemotherapy: North Central Cancer Treatment Group (Alliance) N0923 Study
19. Phase 1 trial of Vismodegib and Erlotinib combination in metastatic pancreatic cancer
20. Ki-67 Labeling Index in Pulmonary Carcinoid Tumors: Comparison Between Small Biopsy and Resection Using Tumor Tracing and Hot Spot Methods
21. A phase I study of the VEGFR kinase inhibitor vatalanib in combination with the mTOR inhibitor, everolimus, in patients with advanced solid tumors
22. Oncolytic Measles Virotherapy and Opposition to Measles Vaccination
23. Non–Small Cell Lung Cancer: Epidemiology, Screening, Diagnosis, and Treatment
24. BAP1 loss is unusual in well-differentiated papillary mesothelioma and may predict development of malignant mesothelioma
25. Sarcomatoid Carcinoma of the Lung: The Mayo Clinic Experience in 127 Patients
26. ‘Would you make your very best case’: enforcing lobbying regulations through stipulation practice
27. A phase I study of the vascular endothelial growth factor inhibitor Vatalanib in combination with Pemetrexed disodium in patients with advanced solid tumors
28. A phase I study of the farnesyltransferase inhibitor Tipifarnib in combination with the epidermal growth factor tyrosine kinase inhibitor Erlotinib in patients with advanced solid tumors
29. Management of Multifocal Lung Cancer: Results of a Survey
30. Pulmonary Neuroendocrine Tumors: Adjuvant and Systemic Treatments
31. Phase 1/2 trial of vesicular stomatitis virus expressing human interferon-β and NIS (VSV-IFNβ-NIS), with ipilimumab and nivolumab, in patients with neuroendocrine carcinoma.
32. Abstract 12820: Beta Blocker Use and Peri-operative Outcomes in Cancer Patients Receiving Immunotherapy
33. Efficacy of Second-Line Chemotherapy in Extrapulmonary Neuroendocrine Carcinoma
34. A safety, tolerability, and pharmacokinetic analysis of two phase I studies of multitargeted small molecule tyrosine kinase inhibitor XL647 with an intermittent and continuous dosing schedule in patients with advanced solid malignancies
35. c-Met expression and MET amplification in malignant pleural mesothelioma
36. Pembrolizumab versus docetaxel for previously treated, PD-L1-positive, advanced non-small-cell lung cancer (KEYNOTE-010): a randomised controlled trial
37. Book review: Urban Violence: Security, Imaginary, Atmosphere.
38. PFKFB3 inhibition reprograms malignant pleural mesothelioma to nutrient stress-induced macropinocytosis and ER stress as independent binary adaptive responses
39. "A modern research profession': government social research, evidence-based policymaking and blind spots in contemporary governance research.
40. Nomograms Predict Overall Survival for Patients with Small-Cell Lung Cancer Incorporating Pretreatment Peripheral Blood Markers
41. The DNA Methyltransferase DNMT1 and Tyrosine-Protein Kinase KIT Cooperatively Promote Resistance to 5-Aza-2′-deoxycytidine (Decitabine) and Midostaurin (PKC412) in Lung Cancer Cells
42. Dopamine D2 receptor agonists inhibit lung cancer progression by reducing angiogenesis and tumor infiltrating myeloid derived suppressor cells
43. A Phase I/II Study of Bortezomib in Combination with Paclitaxel, Carboplatin, and Concurrent Thoracic Radiation Therapy for Non–Small-Cell Lung Cancer: North Central Cancer Treatment Group (NCCTG)-N0321
44. A phase I study of cilengitide and paclitaxel in patients with advanced solid tumors
45. NCCTG N0821 (Alliance): A Phase II First-Line Study of Pemetrexed, Carboplatin, and Bevacizumab in Elderly Patients with Advanced Nonsquamous Non–Small-Cell Lung Cancer With Good Performance Status
46. A phase II trial of the Src-kinase inhibitor saracatinib after four cycles of chemotherapy for patients with extensive stage small cell lung cancer: NCCTG trial N-0621
47. Adjuvant chemoradiation therapy with high-dose versus weekly cisplatin for resected, locally-advanced HPV/p16-positive and negative head and neck squamous cell carcinoma
48. Modeling the Rainfall Exploitation of the Reservoirs in Malaga Province, Spain.
49. A Randomized Phase II Study of Gemcitabine and Carboplatin with or without Cediranib as First-Line Therapy in Advanced Non–Small-Cell Lung Cancer: North Central Cancer Treatment Group Study N0528
50. Bi-Objective Bus Routing: An Application to School Buses in Rural Areas
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.